---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-089981"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:29:42.209199+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Tivic Health terminates ALOM fulfillment agreement to reduce costs, transitions to in-house ops

## Summary
- Effective August 1, 2024, terminated ALOM Fulfillment Services Agreement for convenience; no material early termination penalties.
- Transitioned to alternate third-party logistics and in-house assembly/testing; no service disruption and capacity sufficient for foreseeable demand.
- Minimum monthly purchase requirement of $25,000 was waived from January through June 2024 prior to termination.

## SEC filing metadata
- accession: 0000950170-24-089981
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017024089981/0000950170-24-089981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017024089981/tivc-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-089981
- JSON: https://secwatch.observer/filing/0000950170-24-089981.json
- Plain text: https://secwatch.observer/filing/0000950170-24-089981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.